Navigation Links
New clinical definition for epilepsy improves diagnosis accuracy
Date:4/13/2014

An expert task force has created a new definition for epilepsy that refines the scope of patients diagnosed with this brain disease. The study published in Epilepsia, a journal published by Wiley on behalf of the International League Against Epilepsy (ILAE), provides a greater level of detail to diagnose epilepsy by including individuals with two unprovoked seizures, and those with one unprovoked seizure and other factors that increase risk of seizure recurrence.

The 2005 report by the ILAE task force defined an epileptic seizure as "a transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain" and epilepsy as "a disorder of the brain characterized by an enduring predisposition to generate epileptic seizures, and by the neurobiologic, cognitive, psychological, and social consequences of this condition. The definition of epilepsy requires the occurrence of at least one epileptic seizure."

"Why change the definition of epilepsy?" asks task force lead author Dr. Robert Fisher from Stanford University School of Medicine. "The 2005 definition does not allow a patient to outgrow epilepsy, nor does it take into account some clinicians' views that epilepsy is present after a first unprovoked seizure when there is a high risk for another. The task force recommendation resolves these issues with the new, more practical, definition of epilepsy that is aimed at clinicians. However, some researchers might use criteria similar to those of the older definition to facilitate comparison with prior studies."

The task force suggests that epilepsy is a disease of the brain defined as:

    1. At least two unprovoked (or reflex) seizures occurring more than 24 hours apart; or

    2. One unprovoked (or reflex) seizure and a probability of further seizures similar to the general recurrence risk (at least 60%) after two unprovoked seizures, occurring over the next 10 years; or

    3. Diagnosis of an epilepsy syndrome.

"The burden of determining recurrence risk does not fall on the clinician. If information is not available on recurrence risk after a first seizure, then the definition defaults to the old definition," adds Dr. Fisher. According to the article epilepsy is "resolved" in individuals who are past the applicable age of an age-dependent epilepsy syndrome, or those that have been free of seizures for the last 10 years and off anti-epileptic drugs (AEDs) for 5 years or more. The authors note that, the meaning of "resolved" is not identical to that of "remission" or "cure."

"The published definitions were supported with factual data, but in some cases medical evidence did not exist and the task force used a "consensus" approach for these definitions," explains Drs. Gary Mathern and Astrid Nehlig, Editors-in-Chief of Epilepsia. In these instances, the editors are asking readers' opinions adding, "We encourage you to go to http://surveys.verticalresponse.com/a/show/1539433/ea840f4206/0 to share your feedback regarding the new definition of epilepsy."


'/>"/>

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley
Source:Eurekalert

Related medicine news :

1. Moffitt Cancer Center begins Phase I clinical trial of new immunotherapy
2. HPV eradicated by AHCC supplement, preclinical study suggests
3. Miriam Hospital receives renewal of NIH grant for AIDS Clinical Trials Group
4. Kessler Foundation MS scientist awarded Patterson Trust Award in Clinical Research
5. Multidisciplinary research team led by Tufts CTSI proposes new model for clinical trials
6. Clinical trial identifies women most likely to benefit from vaginal mesh surgery
7. Myriad publishes clinical utility study for Prolaris
8. UNC receives more than $40 for global clinical trials unit to treat and prevent HIV
9. Clinical opinion published on use of maternal oxygen during labor
10. REACT clinical trial supports new approach of accelerated treatment for Crohns disease
11. Cell therapy shows remarkable ability to eradicate cancer in clinical study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... ... “Glimpses Of Light”: is a unique and thought inspiring guide toward ... of published author, J.M. Shepherd, a writer, teacher, traveler, and metaphysician, the author has ... Shepherd shares, “Love is one of the least understood and yet most sought-after pleasures ...
(Date:8/22/2017)... ... 2017 , ... Although Labor Day is not as popular for fireworks as ... displays, and numerous households celebrate the unofficial end of summer with backyard fireworks shows. ... , Kris Zambo, owner of Dynamite Fireworks in Hammond, Indiana, provides ...
(Date:8/21/2017)... ... August 21, 2017 , ... ... of two plastic surgery fellows for academic year 2017-2018, Christina M. Busuito, M.D. ... have successfully completed residency in Plastic and Reconstructive Surgery. The candidate will ...
(Date:8/21/2017)... ... August 21, 2017 , ... Marathon running ... over the country. , Outdoor running increases exposure to ultraviolet radiation, a carcinogen ... risk of melanoma, and only half may be adequately protecting themselves with proper ...
(Date:8/21/2017)... ... August 21, 2017 , ... The American Hospital Association (AHA) has elected ... Health company, to its Board of Trustees for a three-year term beginning January 1, ... provider organizations and individuals that are committed to the improvement of health in their ...
Breaking Medicine News(10 mins):
(Date:8/17/2017)... ANGELES , Aug. 17, 2017 MJAC2017 ... CBMJ – Canna Broadcast Media, today reveals its leading lineup. ... Isodiol International Inc., a global cannabis innovator specializing in the ... sponsor of the conference. MassRoots, Rambridge™ and The Green Organic ... Bay Inc. and Namaste Vapes™ as silver sponsors. ...
(Date:8/15/2017)... Mich. , Aug. 15, 2017 Diplomat ... naloxone to Michigan residents. ... Flint retail pharmacy, G-3320 Beecher ... approved by the Food and Drug Administration, is intended ... extreme drowsiness, slowed breathing, and loss of consciousness. The ...
(Date:8/14/2017)... Israel , Aug. 15, 2017  BrainStorm ... adult stem cell technologies for neurodegenerative diseases, announced financial ... "We are in ... 3 trial to investigate NurOwn ® in ALS," ... Officer of BrainStorm. "We have agreements with Mass. General ...
Breaking Medicine Technology: